Top Markets
Coin of the day
Nextgen Biomed Ltd Nextgen Biomed Ltd

Nextgen Biomed Ltd

NXGN
Rank in Stocks #37893
Nextgen Biomed Ltd focuses on developing external dermatological treatments for... Nextgen Biomed Ltd focuses on developing external dermatological treatments for psoriasis. The company, which was established in 1990, originally operated under the name Sela Group.Com Ltd. before rebranding as Nextgen Biomed Ltd in February 2010. Its operations are headquartered in Tel Aviv, Israel.
Share Price
$0.14896012
Last synced: 2026-02-16
Market Cap
$1.37M
Change (1 day)
-2.89%
Change (1 year)
-19.65%
Country
IL
Trade Nextgen Biomed Ltd (NXGN)

Category

Operating Margin for Nextgen Biomed Ltd (NXGN)
Operating Margin as of 2026 TTM: 0.00%
According to Nextgen Biomed Ltd latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Nextgen Biomed Ltd from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
31.28% -
US
12.36% -
FR
0.00% -
JP
10.61% -
US
0.00% -
CH
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.